Identification of a TOP3A genetic variant as a novel biomarker for sensitivity to doxorubicin
{{output}}
Introduction: Doxorubicin (DOX), though an effective cytostatic drug, is associated with dose limiting toxicities. Consequently, mandated cumulative-dose restriction may result in compromised tumour control. Improved characterisa... ...